Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6628369 | 0.98 | LTA4H (0.54) | LTA4HHTTHRH3EPHX2 | |
| SCHEMBL3367622 | 0.96 | LTA4H (0.48) | LTA4HHTTIDO1 | |
| SCHEMBL622656 | 0.92 | IDO1 (0.50) | IDO1 | |
| Ammonia Solution, Strong SCHEMBL8172708 | 0.90 | IDO1 (0.48) | IDO1 | |
| SCHEMBL13504115 | 0.85 | OPRK1 (0.51) | — | |
| SCHEMBL5516474 | 0.83 | CYP26A1 (0.47) | — | |
| SCHEMBL3964389 | 0.83 | CYP19A1 (0.47) | — | |
| SCHEMBL9340622 | 0.83 | SMN1; SMN2 (0.51) | — | |
| SCHEMBL22023702 | 0.83 | HRH3 (0.52) | HRH3 | |
| SCHEMBL11465115 | 0.83 | CYP26A1 (0.43) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1401388-B1 | FRAGRANCE AND FLAVOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2010-06-16 | — | — | EP | claimed |
| US-20050042255-A1 | Fragrance and flavour compositions | GIVAUDAN SA (CH) | 2005-02-24 | — | — | US | claimed |
| EP-1401388-A2 | FRAGRANCE AND FLAVOUR COMPOSITIONS | Givaudan SA (CH) | 2004-03-31 | — | — | EP | claimed |
| WO-2003002084-A2 | FRAGRANCE AND FLAVOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2003-01-09 | — | — | WO | claimed |
| EP-1269982-A1 | Fragrance and flavour compositions | Givaudan SA (CH) | 2003-01-02 | — | — | EP | claimed |
| US-20230398077-A1 | SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-12-14 | — | — | US | disclosed |
| US-10675300-B2 | Group 3 metal compounds and use thereof in the treatment of solid tumors | Università degli Studi di Salerno (IT) | 2020-06-09 | — | — | US | disclosed |
| US-20190240254-A1 | Group 3 Metal Compounds and Use Thereof in the Treatment of Solid Tumors | Università degli Studi di Salerno (IT) | 2019-08-08 | — | — | US | disclosed |
| EP-1401388-B1 | FRAGRANCE AND FLAVOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2010-06-16 | — | — | EP | disclosed |
| US-7704942-B2 | Fragrance and flavour compositions | GIVAUDAN SA (CH) | 2010-04-27 | — | — | US | disclosed |
| US-20050042255-A1 | Fragrance and flavour compositions | GIVAUDAN SA (CH) | 2005-02-24 | — | — | US | disclosed |
| EP-1401388-A2 | FRAGRANCE AND FLAVOUR COMPOSITIONS | Givaudan SA (CH) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003002084-A2 | FRAGRANCE AND FLAVOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2003-01-09 | — | — | WO | disclosed |
| EP-1269982-A1 | Fragrance and flavour compositions | Givaudan SA (CH) | 2003-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050042255-A1 | Fragrance and flavour compositions | C5, FAAH2, TRPA1 | LTA4H 99/4885HTT 2813/4885HRH3 184/4885 |
| US-20190240254-A1 | Group 3 Metal Compounds and Use Thereof in the Treatment of Solid Tumors | CA4, CA13, CA14 | LTA4H 3723/4885HTT 4486/4885HRH3 2885/4885 |
| US-20230398077-A1 | SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY | CD47, SGMS1, ABCC1 | LTA4H 4229/4885HTT 2129/4885HRH3 4718/4885 |
| US-10675300-B2 | Group 3 metal compounds and use thereof in the treatment of solid tumors | CA4, CA13, CA14 | LTA4H 3723/4885HTT 4486/4885HRH3 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.